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Cysteinyl leukotrienes (CysLTs) and lipoxins (LXs) are lipid mediators that control inflammation, with the former inducing and
the latter inhibiting this process. Because the role played by these mediators in paracoccidioidomycosis was not investigated, we
aimed to characterize the role of CysLT in the pulmonary infection developed by resistant (A/J) and susceptible (B10.A) mice.
48 h after infection, elevated levels of pulmonary LTC
4
and LXA
4
were produced by both mouse strains, but higher levels were
found in the lungs of susceptible mice. Blocking the CysLTs receptor by MTL reduced fungal loads in B10.A, but not in A/J mice.
In susceptible mice, MLT treatment led to reduced influx of PMN leukocytes, increased recruitment of monocytes, predominant
synthesis of anti-inflammatory cytokines, and augmented expression of 5- and 15-lipoxygenasemRNA, suggesting a prevalent LXA
4
activity. In agreement, MTL-treated macrophages showed reduced fungal burdens associated with decreased ingestion of fungal
cells. Furthermore, the addition of exogenous LX reduced, and the specific blockade of the LX receptor increased the fungal loads
of B10.A macrophages. This study showed for the first time that inhibition of CysLTs signaling results in less severe pulmonary
paracoccidioidomycosis that occurs in parallel with elevated LX activity and reduced infection of macrophages.
1. Introduction
Paracoccidioidomycosis (PCM) is a chronic systemic infec-
tious disease of Latin America caused by the dimorphic
fungus Paracoccidioides brasiliensis. The infection is usually
acquired by the respiratory route probably by inhalation
of airborne propagules [1]. The disease has a wide gamut
of clinical and immunopathological manifestations. High
antibody titers and suppressed T cell mediated immunity
characterize the severe forms of the disease whereas the
opposite pattern of immunity is associated with mild PCM
[2].
Our laboratory developed an isogenic murine model of
paracoccidioidomycosis where A/J and B10.A mice mimic
the benign and severe forms of the disease, respectively. A/J
mice develop a regressive infection characterized by intense
cellular immunity and organized lesions. In contrast, B10.A
mice show a progressive disease associated with suppressed T
cell immunity and intense tissue pathology caused by fungi-
rich disorganized lesions [3, 4]. IFN-𝛾 is the main protective
cytokine to pulmonary PCM, and IFN-𝛾 depletion causes
more severe disease in both, susceptible and resistant mice
[5].The innate immunity of these polarmouse strains appears
to be paradoxical to the patterns of adaptive immunity they
develop. Early in the infection, susceptible mice mount a
proinflammatory response mediated by intense IL-12 and
nitric oxide production that induce an M1 phenotype in
macrophages and DCs, which are able to control the initial
fungal growth. In contrast, the innate response of resistant
mice is predominantly TGF-𝛽 mediated, resulting in an M2
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profile of macrophages and DCs that are permissive to fungal
growth. However, the tolerogenic response of A/J mice is
concomitant with the development of immunogenic DCs
that secrete high levels of TNF-𝛼 and induce the activation
of protective T cell immunity. In contrast, the excessive
proinflammatory innate immunity of B10.A mice induces an
early energy of T cells that leads to progressive disease [6–9].
The inflammatory reaction is a complex and multimediated
phenomenon that comprises the synergistic action of several
mediators such as the eicosanoids derived from arachidonic
acid (AA) metabolism. The enzymatic oxidation of AA
by cyclooxygenase produces prostaglandins, thromboxanes,
and prostacyclins whereas the 5-lipoxygenase (5-LO) is an
enzyme that in the presence of FLAP (Five Lipoxygenase
Activating Protein) catalyzes the oxidation of AA for the
synthesis of leukotrienes (LTs) and lipoxins (LXs).The unsta-
ble intermediate LTA4 generated by 5-LO can be converted
to LTB4 by enzymatic hydrolysis or, by incorporating the
glutathione residue, can be converted to LTC
4
, LTD
4
, and
LTE
4
, collectively called Cysteinyl LTs (CysLTs) [10–13].
To date, four LT receptors have been described, B
leukotriene receptors 1 and 2 (BLT1 and BLT2) and cysteinyl
leukotriene receptors 1 and 2 (CysLT
1
and CysLT
2
) [14, 15].
The lipoxins are mainly involved in the resolution of inflam-
matory reactions and are synthesized by twomain transcellu-
lar routes. One involves platelets/leukocytes interaction and
the conversion of 5-LO-derived LTA
4
into LXA
4
and LXB
4
by the enzymatic action of 12-LO. The second pathway is
initiated by 15-LO that produces 15S-HETE from AA that is
rapidly converted to LX by 5-LO [13]. The anti-inflammatory
effects of lipoxins are mediated by an LX receptor termed
ALX and include inhibition of PMN neutrophils chemotaxis,
modulation of cytokines synthesis, and inhibition of cell
proliferation [13, 16].
The importance of the LTs as inflammatorymediators and
their function in the host defense against infectious agents
are well established [11, 12]. In several studies, LTs have been
shown to participate in the microbicidal ability of phago-
cytes, in vivo clearance of pathogens, regulation of cytokine
production, and control of the influx of inflammatory cells
to the site of infection [17–23]. Although less investigated,
the anti-inflammatory lipoxins were also described to play
a regulatory role in infections caused by protozoan and
bacterial infections [24, 25].
In pulmonary histoplasmosis, LTs were shown to exert
a protective role mediated by the control of fungal burden,
cytokines production, and the influx of effector and memory
T cells into the lungs [26, 27].The influence of lipidmediators
from the AAmetabolism was scarcely studied in paracoccid-
ioidomycosis. However, some studies have shown that PGE
2
impairs the fungicidal ability of macrophages and induces
an early immunosuppression in P. brasiliensis infected mice
[28–30]. Interestingly, an endogenous synthesis of PGE and
LTB
4
by P. brasiliensis yeasts was also described, suggesting
that fungal cells could use these eicosanoids to modulate host
immune responses [31–33]. The role played by LTs in murine
paracoccidioidomycosis is still controversial and opposite
results showing deleterious or beneficial effects have been
recently reported [34–36].
To further elucidate the role of LTs in murine paracoccid-
ioidomycosis, we aimed to investigate the role of CysLTs in
the in vitro and in vivo infections caused by P. brasiliensis.The
influence of montelukast (MTL), an antagonist of the CysLT
1
receptor, was studied in the acute and chronic phases of
pulmonary PCMdeveloped by resistant and susceptiblemice.
We verified that susceptible mice secreted higher levels of LTs
and LXs than resistantmice, and only the former strain devel-
oped a less severe early infection when CysLTR
1
was blocked.
The reduced fungal burden induced by MTL treatment was
associated with alteredmigration of inflammatory cells to the
lungs, decreased production of proinflammatory cytokines
allied with increased levels of IL-10, and typical responses
of predominant LX signaling. In vitro studies replicated our
in vivo findings: decreased phagocytic activity and reduced
fungal loads were recovered when CysLTR
1
signaling was
inhibited. Moreover, addition of exogenous LX reduced the
fungal loads, whereas the blockade of LX receptor increased
the fungal loads of macrophages. In conclusion, CysLTs and
LXs appear to influence innate immunity of P. brasiliensis
infected hosts. Inhibited CysLTs signaling appears to result in
predominant LX activity that reduces P. brasiliensis infection.
This is an unusual finding, but it adds to others consistently
obtained in our model, demonstrating that the uncontrolled
activation of the immune system can lead to a more severe
PCM [6–9, 37–40].
2. Materials and Methods
2.1. Ethics Statement. Animal experiments were performed
in strict accordance with the Brazilian Federal Law 11, 794,
establishing procedures for the scientific use of animals,
and the State Law establishing the Animal Protection Code
of the State of Sa˜o Paulo. All efforts were made to min-
imize suffering, and all animal procedures were approved
by the Ethics Committee on Animal Experiments of the
Institute of Biomedical Sciences of University of Sa˜o Paulo
(Proc.76/04/CEEA).
2.2. Mouse Strains. Unless otherwise stated, groups of 6 to
8 male mice (9 to 11 weeks old) from the susceptible (B10.A)
and resistant (A/J) strains toP. brasiliensis infectionwere used
for each period of infection. Male 5-LO knockout (KO, 129-
Alo5trnIFun) and strain matched wild type (WT) SV/129 mice
were obtained from the Jackson Laboratory. All the animals
were bred at the University of Sa˜o Paulo animal facilities
and provided with acidified water and sterilized food and
bedding. All efforts were made to minimize suffering, and all
animal procedures were approved by the Ethics Committee
on Animal Experiments of the Institute of Biomedical Sci-
ences of University of Sa˜o Paulo (Proc.76/04/CEEA).
2.3. P. brasiliensis Infection. P. brasiliensis 18 (Pb18) isolate,
which is highly virulent, was used throughout this study [41].
Pb18 yeast cells were maintained by weekly subcultivation
in semisolid Fava Netto’s culture medium [42] at 35∘C and
used at the 7th day in culture. Mice were anesthetized
and submitted to i.t. P. brasiliensis infection as previously
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described [43]. Briefly, after i.p. anesthesia, the animals were
infectedwith 1× 106, 1× 105, or 1× 104 P. brasiliensis Pb18 yeast
cells, contained in 50𝜇L of PBS, by surgical i.t. inoculation
that allowed dispensing the fungal cells directly into the
lungs.
2.4. Administration of CysLTR1 Inhibitor. Montelukast (MTL,
Singular, trade name), a CysLTs antagonist that blocks the
action of leukotrienes on the cysteinyl leukotriene receptor-1
(CysLTR
1
), was purchased from Merck Sharp & Dome. For
in vivo experiments, MTL was administered via oral route
(10mg/kg/day) in the drink water, and the required drug
dilution was prepared immediately before use [44]. MTL
treatment started at day −1 of infection and remained for
the next two days, when mice were sacrificed. Control mice
received equivalent quantities of vehicle in the drinking
water. Mice were maintained in individual cages and drug
intake monitored by daily differences in water volume. Two
treatment schedules were employed for experiments of 8
weeks of infection. One group received 10mg/kg/day during
11 days, and the other group received the same dose during
the whole time of the experiment.
2.5. Assay for Organ Colony Forming Units (CFU). The num-
ber of viable microorganisms in the lungs, liver, and spleen
from drug-treated and untreated mice was determined by
counting the number of CFU. Six to eight animals from each
group were sacrificed 48 h and 8 weeks after infection and the
enumeration of viable organism in the three organs was done
as previously described [45]. Briefly, aliquots (100 𝜇L) of the
cellular suspensions of each organ were plated on brain heart
infusion (BHI) agar (Difco) supplemented with 4% (vol./vol.)
horse serum (Instituto Butantan, Sa˜o Paulo, Brazil) and 5%
Pb192 culture filtrate, the latter constituting a source of
growth-promoting factor. The plates were incubated at 35∘C
and colonies were counted daily until no increase in counts
was observed. The numbers (log
10
) of viable P. brasilien-
sis colonies per gram of tissue are expressed as means ±
standard errors.
2.6. Measurement of Cytokines and NO. The mice were
infected i.t. with P. brasiliensis and 48 h or 8 weeks later
their lungs were aseptically removed and disrupted in 4.0mL
of RPMI 1640 medium (Gibco BRL). Supernatants were
separated from cell debris by centrifugation at 2,000×g for
15min, passed through 0.22-𝜇m pore-size filters (Millipore),
and stored at −70∘C. Cytokines (TNF-𝛼, GM-CSF, IL-12, IL-
10, IFN-𝛾, IL-2, IL-4, IL-5, IL-17, and IL-23) and chemokine
(MCP-1) levels were measured by capture enzyme-linked
immunosorbent assay (ELISA) with antibody pairs pur-
chased from BD Pharmingen. The ELISA procedure was
performed according to the manufacturer’s protocol and
absorbance was measured with VersaMax Microplate Reader
(Molecular Devices). NO production was quantified by the
accumulation of nitrite in the supernatants from in vitro
and in vivo protocols by a standard Griess reaction [46]. All
determinations were performed in triplicate and expressed as
𝜇MNO.
2.7. Assessment of Lung Inflammatory Exudates by Flow
Cytometry. After 48 h of infection, lungs from each mouse
were digested enzymatically for 30 minutes with collagenase
(1mg/mL) in culture medium (Sigma). Lung cells suspen-
sions were centrifuged in presence of 20% Percoll (Sigma)
to separate leukocytes from cell debris. Total lung leukocyte
numbers were assessed in the presence of trypan blue using
a hemocytometer; viability was >85%. The lung leukocytes
were resuspended at 106 cells/mL in staining buffer (PBS +
0.1% NaN3 + and 1% fetal calf serum). Fc receptors were
blocked by unlabeled anti-CD16/32 antibodies (BD Bio-
sciences) and cells were stained for 20 minutes at 4∘C by
phycoerythrin-labeled (PE) anti-Dectin-1 and TLR4; fluo-
rescein isothiocyanate-labeled (FITC) anti-MR and TLR2;
Peridinin Chlorophyll Protein Complex (PerCP) Cy5.5 anti-
CD11b; Pacific Blue (PB) anti-F4/80 monoclonal antibodies
(BD Biosciences, eBiosciences). Cells were fixed with 2%
paraformaldehyde (Sigma) and stored in the dark at 4∘C until
analyzed in a flow cytometer FACSCanto (BD Bioscience).
The acquisition and analysis gates were restricted to the
macrophages using the FlowJo software (Tree Star, Inc.).
2.8. Quantitative Analysis of mRNA Expression. After 48 h
of infection, lungs from each mouse were removed and
RNA was extracted using Trizol reagents. The RNA con-
centrations were determined by spectrophotometer readings
at an absorbance of 260 nm. First-strand cDNAs were syn-
thesized from 2 𝜇g RNA using the High Capacity RNA-
to-cDNA kit (Applied Biosystems) according to the man-
ufacturer’s instructions. Real-time polymerase chain reac-
tion (RT-PCR) specific for ALOX5 (Mm PT58.30176779),
ALOX15 (Mm00507789 m1), NOS2 (Mm00440502 m1), and
ARG1 (Mm00475988 m1) (Applied Biosystems, Life Tech-
nologies) was performed using the TaqMan real-time PCR
assay (Applied Biosystems, Life Technologies) or Sybr Green
(Applied Biosystems, Life Technologies) according to the
manufacturer’s instructions. Analysis was performedwith the
Stratagene Mx3005P detection system (GE electronics). All
values were normalized to GAPDH or HPRT and the relative
gene expression calculated.
2.9. Leukocyte Subsets in Bronchoalveolar Lavage Fluid
(BALF). Two days after infection, lungs of mice were lavaged
after the cannulation of trachea with polyethylene tubing,
which was attached on a tuberculin syringe. The same pro-
cedure was applied to sham-infected (submitted to surgical
stress and injected with 50𝜇L of PBS) and normal mice
of both mouse strains. The lungs were lavaged by repeated
injections of 0.5mL of sterile PBS (final volume, 2.0mL).
The recovered fluid was cytospun at 1,200 rpm (Shandon
Cytospin, Pittsburgh, PA) onto glass slides and stained by
the Diff-Quik blood stain (Baxter Scientific, Miami, Fla);
the supernatant was removed and cells were analyzed for
leukocyte subsets.The frequency of polymorphonuclear neu-
trophils, lymphocytes, and macrophages were morphologi-
cally evaluated, and the absolute cell number was calculated
based on the total cell counts of BALF.
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2.10. Fluorescein Isothiocyanate-Labeling (FITC) of P.
brasiliensis Yeasts. P. brasiliensis yeasts were washed in
phosphate buffered saline (PBS) and heat-killed at 60∘C
for 1 hr. Before labeling, the yeast suspension was sonicated
using 3 cycles of 10 seconds each (21% amplitude) with
Sonics (Vibra Cell VCX 750, Sonics & Materials) to
eliminate aggregates. The yeasts were washed, adjusted to
1 × 106 cells/mL in PBS, and then incubated with FITC
(100 𝜇g/mL, Sigma) for 30min. at 37∘C.The yeast suspension
was then washed tree times with PBS and stored at 4∘C.
2.11. Phagocytic and Fungicidal Assays. Thioglycollate-
induced peritoneal macrophages were isolated by adherence
(2 h at 37∘C in 5% CO
2
) to plastic-bottom tissue-culture
plates (1 × 106 cells/well in 24-well plates for fungicidal
assays). Macrophages were washed to remove nonadherent
cells and cultivated overnight with fresh complete medium
(DMEM, Dulbecco’s Modified Eagle’s Medium, Sigma)
containing 10% fetal calf serum, 100U/mL penicillin, and
100 𝜇g/mL streptomycin in the presence or absence of
recombinant IFN-𝛾 (20 ng/mL in culture medium, BD-
Pharmingen). For phagocytic assays, IFN-𝛾 primed and
unprimed macrophages were pretreated or not with MTL
in the concentrations indicated in the legends for 60min
and were infected with P. brasiliensis yeasts labeled with
fluorescein isothiocyanate (FITC) in a macrophage : yeast
ratio of 1 : 1 [7, 40]. The cells were cultivated for 2 h at 37∘C in
5% CO
2
to allow fungi adhesion and ingestion. Supernatants
were removed and cells were gently washed with PBS to
remove any noningested or nonadhered yeasts. Cells were
then harvested and the macrophages were then labeled with
anti-CD11b APC (eBioscience) for 20min at 4∘C. Because
P. brasiliensis yeast cells have a high variability in size and
granularity (different sizes, number of buds, and number of
nuclei), the granulocytes gates as defined by size (FSC) and
granularity (SSC) to determine the macrophage population
were not used. The total cells present in the samples were
analyzed by flow cytometry (FACSCalibur, BD-Pharmingen).
For the distinction between internalized and surface-bound
yeasts (FITC-labeled P. brasiliensis particles), trypan blue
(TB, 250mg/mL, Sigma) was used for quenching the green
surface-bound fluorescence on macrophages. TB quenching
technique was performed as previously described [40].
Phagocytic assays were performed as described above and
adherent/ingested cells measured using the FL1 and FL4
channels of a FACSCalibur cytometer. Cell suspensions were
then treated in an ice bath with 0.1mL of a TB solution
prepared in 0.1M citrate buffer, pH 4.0, lowering samples pH
to nearly 4.0, thereby optimizing the TB quenching effect.
After 1min of incubation in ice bath, the samples were again
analyzed. APC-labeled macrophages were gated, and FL1
and FL3 channels were used to discriminate ingested (green
fluorescent, FL1) from adherent (red fluorescent, FL3) yeasts.
For fungicidal assays, IFN-𝛾 primed and unprimed
macrophages were pretreated with three different concen-
trations of MTL, lipoxin (Cayman Chemical, MI, USA)
orN-t-BOC-methionyl-L-leucyl-phenylalanine (BocMLP), a
known formyl peptide receptor antagonist (MP Biomedicals,
France) for 60min before infection with P. brasiliensis in a
macrophage : yeast ratio of 50 : 1, and cocultivated for 2 h. It
was previously verified that the employed concentrations of
MTL had no adverse effects on macrophages or P. brasiliensis
viability as determined by trypan blue and JanusGreen B vital
dye assays, respectively. The monolayers were then washed
to remove nonadherent cells and incubated for an additional
48 h period. Plates were centrifuged (400×g, 10min, 4∘C),
and supernatants were obtained and stored at −70∘C and
further analyzed for the presence of nitrite and cytokines.The
wells were washed with distilled water to lyse macrophages,
and suspensions were collected in individual tubes. One
hundred 𝜇L of cell homogenates was assayed for the presence
of viable yeasts. All assays were done with five wells per
condition in over three independent experiments.
2.12. Measurement of Eicosanoids. Lung homogenates from
B10.A and A/J mice were collected as described above. Lipids
were purified from filtered lung homogenate supernatants
with Sep-Pak C18 cartridges according to the instructions
of the manufacturer (Waters Corp., Milford, MA). Levels
of eicosanoids were measured using commercial ELISA kits
obtained from Neogen Corp (LXA4), Cayman Chemical Co.
(PGE
2
, LTC
4
). The limit of assay detection for LTC
4
, PGE
2
,
and LXA
4
was 10 pg/mL.
2.13. Statistical Analysis. Data were analyzed by Student’s 𝑡-
test or two-way analysis of variance depending on the number
of experimental groups using GraphPad Prism software
(GraphPad Software). 𝑝 values under 0.05 were considered
significant.
3. Results
3.1. P. brasiliensis Infection Induces the Production of LTC4,
LXA4, and PGE2 by Resistant and Susceptible Mice. Before
studying the effect of CysLT
1
blockade in pulmonary PCM,
we first asked if P. brasiliensis infection induces the produc-
tion of lipid mediators. Thus, the levels of LTC
4
, (the major
class of LTs produced in murine lungs), LXA
4
, and PGE
2
were measured in the lung homogenates of infected resistant
and susceptible mice. Susceptible (B10.A) and resistant mice
(A/J) were infected with one million P. brasiliensis yeast
cells and sacrificed 48 h later and their lung homogenates
were assessed for the presence of eicosanoids. Figure 1(a)
demonstrates that P. brasiliensis infection induced the pro-
duction of LTC
4
by bothmouse strains, but higher levels were
found in the lungs of susceptible mice. LXA
4
and PGE
2
were
also detected in 48 h lung homogenates (Figures 1(b) and
1(c)). Compared with resistant mice, increased levels of LXA
4
(Figure 1(c)) were found in the lungs of susceptible mice,
but no differences in PGE
2
levels were detected (Figure 1(b)).
Thus, 5-LO-derived products were more prominent in the
lungs of susceptible mice.
3.2. Blockade of CysLTR1 Induces a Less Severe Pulmonary
Infection in Susceptible, but Not in Resistant Mice. To assess
the effect of CysLTR
1
blockade in the severity of infection,
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Figure 1: P. brasiliensis infection induces the production of LTC
4
, LXA
4
, and PGE
2
by resistant and susceptible mice. Levels of lipidmediators
were measured in the lung homogenates of P. brasiliensis (1 × 106 cells) infected resistant (A/J) and susceptible mice (B10.A). The mice were
sacrificed 48 h after infection and their lung homogenates assessed for the presence of LTC
4
(a), LXA
4
(b), and PGE
2
(c) as detailed inMaterials
and Methods. The bars depict means ± SEM of lipid mediator levels of two experiments (5 mice per group). ∗𝑝 < 0.05.
an inoculum of 1 × 106 P. brasiliensis was injected into A/J
and B10.A mice treated or not with MTL during 3 days
(10mg/kg/day by the oral route) starting 24 h before infection
and fungal burdens measured 48 h after infection. As can be
seen in Figure 2(a), decreased numbers of viable P. brasiliensis
yeasts were recovered from lungs of MTL-treated susceptible
mice while no differences were noticed betweenMTL-treated
and untreated resistant mice. This effect of MTL treatment
was also observed with a lower infecting dose (1 × 105
yeast cells) but not with 1 × 104 cells (Figure 2(b)). We
have further measured the levels of nitric oxide (NO) in the
lung homogenates of MTL-treated and untreated B10.A mice
infected with 1 × 106 and 1 × 105 P. brasiliensis yeasts. The
levels of NO detected were proportional to the infecting dose
employed, but no differences were noticed between MTL-
treated and untreated groups (Figure 2(c)).Thus, the reduced
fungal loads observed in MTL-treated mice could not be
ascribed to increase NO production.
3.3. Montelukast Treatment Alters the Expression of ALOX5
and ALOX15 Genes. Because 5-LO and 15-LO enzymes are
involved in the synthesis of LXs, we decided to assess the
influence of MTL treatment in the expression of their genes
(ALOX5 and ALOX15, resp.) by P. brasiliensis infected mice.
Therefore, MTL-treated and untreated A/J and B10.A mice
were infected as previously described, and the expression of
ALOX5 and ALOX15 mRNA was measured by RT-PCR. As
shown in Figure 3, P. brasiliensis infection induced equivalent
levels of ALOX5 mRNA in B10.A and A/J mice; however,
MTL treatment reduced the expression ofALOX5 in the lungs
of A/J mice whereas increased mRNA levels were observed
in B10.A mice. Importantly, higher levels of ALOX15 mRNA
were detected in the lungs of infected B10.A than A/J mice,
and only in B10.A mice MTL treatment increased ALOX15
mRNA expression.
Since LXs have antiflogistic effects on inflammatory
reactions, we have also measured the expression of NOS2
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Figure 2: Blockade of CysLTR
1
induces a less severe pulmonary infection in susceptible but not in resistant mice. 1 × 106 P. brasiliensis yeasts
were inoculated into A/J and B10.A mice treated or not with montelukast (MTL) during 3 days (10mg/kg/day by the oral route) starting 24 h
before infection.The severity of infection was assessed 48 h later by determining fungal loads (CFU) in the lungs (a).The severity of infection
was also assessed in B10.A mice treated or not with MTL and infected with 1 × 105 and 1 × 104 P. brasiliensis yeasts (b). The levels of NO in the
lung homogenates of MTL-treated and untreated B10.A mice infected with 1 × 106 and 1 × 105 P. brasiliensis yeasts were measured by Griess
reagent.The dashed line indicates the levels +/− 2 SD of NO levels measured in the lungs of untreated, noninfectedmice (c). Data aremeans ±
SEM of three experiments, ∗𝑝 < 0.05.
and ARG1 mRNA, respective gene markers of pro- and anti-
inflammatorymacrophages. As we have previously shown [6,
7], infected B10.Amice showed increased expression ofNOS2
whereas A/J mice predominantly expressed ARG1 mRNA.
MTL treatment did not significantly alterNOS2 but increased
ARG1 mRNA expression in both mouse strains.
3.4. Blocking of CysLTR1 Reduces PMN Influx, Production
of Proinflammatory Cytokines, and Expression of Some Pat-
tern Recognition Receptors by Macrophages from Lungs of
P. brasiliensis Infected Mice. Our previous studies demon-
strated that, in comparison with resistant mice, susceptible
mice develop a higher inflammatory cell influx to the lungs
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Figure 3: Blocking of CysLTR
1
alters the expression of ALOX5, ALOX15, NOS2, and ARG1 mRNA. Quantitative PCR analysis of ALOX5,
ALOX15, NOS2, and ARG1 genes expression. A/J and B10.A mice were untreated or treated with montelukast (MTL) during 3 days
(10mg/kg/day by the oral route) starting 24 h before infection and infected with 1 × 106 P. brasiliensis yeasts. Total RNA from whole lungs was
obtained 48 h after infection, reverse transcribed, and cDNA amplified. Real-time PCR was performed using TaqMan universal master mix.
Amplified products were normalized to the amount of GAPDH products. Data represent the means ± SEM of at least 5 mice/group and were
obtained in two independent experiments. (∗𝑝 < 0.01 and ∗∗𝑝 < 0.05).
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Figure 4: Blocking of CysLTR
1
alters the pulmonary inflammatory exudates, the production of cytokines, and the expression of pattern
recognition receptors (PRRs) by P. brasiliensis infected mice. MTL-treated and untreated B10.A mice were infected with 1 × 106 P. brasiliensis
yeasts and the presence of (a) inflammatory cells (macrophages, PMN neutrophils, and lymphocytes) in the bronchoalveolar lavage fluid was
analyzed 48 h later (5-6 mice per group). The cell suspensions were obtained and cytospun onto glass slides. Cells were stained by the Diff-
Quick blood stain. (b)The levels of pulmonary cytokines were measured in lung cell homogenates of MTL-treated and untreated B10.A mice
infected with 1 × 106 P. brasiliensis yeasts. 48 h after infection, lungs were collected, disrupted in 5.0mL of PBS, and supernatants analyzed
for cytokine content by capture ELISA. (c) Median fluorescence intensity (MFI) of PRRs (CD11b, TLR2, TLR4, Dectin-1, and MR) expressed
by F4/80+ lung leukocytes 48 h after P. brasiliensis infection of B10.A mice. The lung and leukocyte suspensions were obtained and stained as
described in materials and methods. Cells were analyzed by flow cytometry, and the acquisition and analysis gates were restricted to F4/80
labeled macrophages. The results are depicted as means ± SEM of two experiments (5-6 mice per group). ∗𝑝 < 0.05.
peaking at 48 h after infection and this difference was mainly
due to increased migration of neutrophils to the lungs
[47]. To study the effect of MTL treatment in the early
inflammatory response, MTL-treated and untreated B10.A
mice were infected with one million P. brasiliensis yeasts and
the presence of inflammatory cells in the bronchoalveolar
lavage fluid was analyzed 48 h later. MTL administration
caused a decreased influx of PMN leukocytes to the alveolar
spaces, associated with increased presence of macrophages
(Figure 4(a)).
To better characterize the effect of CysLTR
1
blockade in
the inflammatory response of B10.A mice, the levels of pul-
monary cytokines were measured in lung cell homogenates
of MTL-treated and untreated B10.A mice (Figure 4(b)). 48 h
after infection, the levels of IL-12 (p70), TNF-𝛼 and GM-CSF
were found significantly diminished in MTL-treated mice.
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No differences were detected in IFN-𝛾 levels, although MTL
treatment resulted in increased levels of IL-10.Thus, blockade
of CysLT signaling induced an enhanced anti-inflammatory
response that was associated with diminished fungal loads in
the lungs.
Because the anti-inflammatory activity of LXA
4
was
previously reported to reduce the expression of comple-
ment receptor 3 (CR3), the main 𝛽2 integrin (CD11b/CD18)
expressed by leukocytes [48], we decided to evaluate the
expression of CD11b and other pathogen recognition recep-
tors [toll-like receptor 2 (TLR2), TLR4, Dectin-1, and man-
nose receptor (MR)] by F4/80+ pulmonary macrophages
of MTL-treated and untreated B10.A mice (Figure 4(c)). A
decreased expression of CD11b and TLR2 concomitant with
increased expression of MR was observed in macrophages of
MTL-treatedmice, suggesting the development of a prevalent
anti-inflammatory milieu.
3.5. Inhibition of CysLT Signaling Does Not Alter the Chronic
Phase of P. brasiliensis Infection but Genetic Deficiency of 5-
LO Results in Less Severe Disease. To determine the effect of
CystLT
1
blockade in the late infection caused by P. brasiliensis
infection, two protocols of MTL treatment were tested. In
the first, MTL was administered by oral route in the dose
of 10mg/kg from day −1 until day 10 after infection with 1
× 106 yeast cells and animals were sacrificed at week 8 after
infection. In the second, mice were treated by oral route
with 10mg/kg during the whole course of infection. Both
protocols did not affect the fungal burdens of B10.A (Figures
5(a) and 5(b)). We have further investigated the effect of
LTs production in the severity of pulmonary PCM developed
by 5-LO genetically deficient mice. No differences in fungal
loads were observed at week 2 after infection (5.32 ± 0.37 and
5.68 ±0 .14 log
10
CFU in the lungs ofWT and 5-LOKOmice,
resp.), but at week 8 decreased CFU counts were detected in
the lungs and livers of 5-LO deficient mice when compared
with WT controls (Figure 5(c)).
3.6. Blockade of CysLTR1 Reduces the Fungal Loads Recovered
from P. brasiliensis Infected Macrophages. The unusual less
severe infection associated with blockade of CysLTs signaling
led us to study the effect of MTL treatment in the interaction
between fungal cells and macrophages. These experiments
were performed by adding different doses of MTL to peri-
toneal macrophages that were subsequently infected with P.
brasiliensis in a macrophage-yeast cells rate of 50 : 1 [6]. The
diverse doses ofMTL employedwere able to reduce the fungal
loads of IFN-𝛾 primed and unprimed B10.A macrophages.
However, in A/J cells, a significant reduction in CFU counts
was only observed in unprimed cells (Figure 6). This result
reproduces our previous in vivo findings with B10.Amice and
demonstrates that the in vitro killing ability of A/J phagocytes
was also affected by MTL treatment.
3.7. MTL Treatment Reduces the Phagocytic Ability of
Macrophages. The unexpected reduced fungal loads induced
by CysTL
1
blockade led us to ask whether this difference
was due to decreased fungal uptake or increased killing
ability of macrophages. We employed a phagocytic assay that
allowed us to distinguish adherent/ingested from ingested
yeast cells. To this end, the interaction of PI-labeled P.
brasiliensis with B10.A and A/J macrophages was measured
before and after fluorescence quenching by trypan blue,
using a cytometric assay that we have previously described
[7, 40]. Macrophage cultures (1 × 106/well) performed in
24-well plates were pretreated or not with three different
concentrations of MTL and infected with heat-killed PI-
labeled yeasts (1 : 1 fungus :macrophage ratio). After 2 h of
incubation, supernatants were aspirated, the monolayer was
gently washed with PBS, and the cells were harvested. To
determine the number of ingested/adhered P. brasiliensis
yeasts, macrophages were incubated with FITC-labeled anti-
CD11b and analyzed by flow cytometry. As shown in Figures
7(a) and 7(b),MTL treatment of IFN-𝛾 primed and unprimed
B10.A macrophages reduced by 57–60% the frequency of
ingested/adhered yeasts. The quenching of extracellular flu-
orescence by trypan blue showed that MTL reduced by
97% the number of ingested yeasts by B10.A macrophages
(Figure 7(c)). MTL-treated A/J macrophages also showed
a reduced adherence (15–20%) and ingestion (18%) of P.
brasiliensis yeasts, but this effect was much less intense than
that observed in B10.A cells (Figures 7(d)–7(f)). This result
suggested that the decreased fungal loads induced by CysLT
1
blockade could be ascribed to the preferential production or
signaling of inhibitory mediators of macrophage functions.
3.8. Exogenous Lipoxin Reduces and Blockade of Lipoxin
Receptor Increases the Fungal Loads of Macrophages. To
further characterize the effect of lipoxin and its receptor in the
interaction between macrophages and P. brasiliensis yeasts,
IFN-𝛾 primed and unprimed macrophage cultures were
treated with several doses of synthetic lipoxin or a specific
antagonist of lipoxin receptor (BOcMLP). As depicted in Fig-
ure 8, the addition of exogenous lipoxin significantly reduced
the fungal burden of IFN-𝛾 primed and unprimed B10.A
macrophages. Furthermore, the blockade of lipoxin receptor
increased the fungal loads of macrophages (Figure 8). These
results led us to infer that lipoxin production and signaling
were able to reduce the severity of infection caused by P.
brasiliensis yeasts.
4. Discussion
The role played by LTs in murine paracoccidioidomycosis
is still controversial. Pharmacological inhibition of LT syn-
thesis employing the FLAP inhibitor MK 886 [35] showed
a protective effect of LTB
4
in the early pulmonary infection
developed by two mouse strains selected for high and low
inflammatory responses [35]. However, two recent reports
using 5-LO deficient C57BL/6mice reported opposite results.
In intravenously infected mice, absence of 5-LO activity
was shown to be protective [34], whereas in intratracheally
infected mice a deleterious effect was observed [36]. Accord-
ing to the former report [34], 5-LO sufficient mice secrete
elevated and sustained levels of LX not observed in 5-LO−/−
mice that develop a less severe disease and enhanced Th1
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Figure 5: Inhibition of CysLT signaling does not alter the chronic phase of P. brasiliensis infection, but 5-LO deficiency results in less severe
disease. MTLwas administered by oral route in the dose of 10mg/kg from day −1 until day 10 (a) or from day −1 until day 56 (b) after infection
with 1 × 106 yeast cells, and B10.Amice were sacrificed at week 8 after infection.The severity of infection was evaluated by determining fungal
loads (CFU assays) in the lungs, livers, and spleens. The effect of LTs production was also studied using mice genetically deficient in the
enzyme 5-LO.The recovery of fungal loads (CFU) from organs of 5-LO−/− and control WT129Svj mice was measured 8 weeks after infection
(c). The bars represent mean ± SEM log
10
numbers of CFU obtained from groups of 5-6 mice. The results were obtained in two independent
experiments. ∗𝑝 < 0.05.
immunity. In contrast, Santos et al. [36] showed an early
mortality of 5-LO−/− mice accompanying an early deficiency
of LTB4 production.These discrepant results led us to further
investigate the role of LTs in i.t. infected mice, a route
that better mimics the human disease. Here, we decided
to investigate the role of CysLTs since (1) they are less
studied than LTB
4
during host defense and (2) murine lung
cells produced ∼10 times more CysLTs than LTB
4
. Using
resistant and susceptible mice to P. brasiliensis infection,
we first verified that the genetic pattern of hosts influence
the synthesis of PGE
2
, LTC
4
, and LXA
4
. Compared with
resistant mice, an increased production of LTC
4
and LXA
4
by
susceptible B10.A mice was observed 48 h after i.t. infection.
Consistent with these data, susceptiblemice expressed higher
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Figure 6: Blockade of CysLTR
1
reduces the fungal loads recovered from P. brasiliensis infected macrophages. MTL (10−8, 10−6, and 10−4M)
treated IFN-𝛾 primed (20 ng/mL) and unprimed peritoneal macrophages from B10.A, and A/J mice were infected with P. brasiliensis in a
macrophage-yeast cells rate of 50 : 1. After 48 h of cocultivation, the monolayers were lysed and assayed for the presence of viable yeast cells
by a CFU assay. Data are means ± SEM of results from quintuplicate samples from three independent experiments. ∗𝑝 < 0.05.
levels of 15-LOmRNA thanA/Jmice possibly explaining their
elevated production of LXA
4.
Furthermore, MTL treated
B10.A mice increased the mRNA expression of 5-LO and 15-
LO mRNA, conceivably increasing the synthesis of LXs and
their inhibitory activities on inflammatory reactions.
Using in vitro and in vivo models of infection, we
could demonstrate for the first time the important role
of CysLTs signaling in pulmonary paracoccidioidomycosis.
Interestingly, and consistent with the levels of eicosanoids
produced, inhibition of CysLT
1
receptor by MTL treatment
modulated the early in vivo infection of susceptible but not
resistant mice. A low number of viable yeasts were recovered
from lungs of B10.A mice 48 h after infection, and this
result was not associated with the increased NO levels, the
most important fungicidal molecule of macrophages [40,
49, 50], indicating that NO-independent mechanisms were
responsible by the less severe P. brasiliensis infection. Our
results have also suggested that the LXA4/LTC4 ratio has an
important influence in the fate of infection. Thus, 48 h after
P. brasiliensis infection of A/J mice, the LXA4/LTC4 ratio was
1.0, whereas in B10.A mice it was 37.5, possibly explaining the
LXA4-governed phenotypes observed only in the susceptible
mouse strain.
At the chronic phase of infection, MTL treatment did not
influence the severity of the disease indicating a prevalent
action of CysLTs at the innate phase of immunity. In contrast,
decreased fungal loadswere observed in 5-LO−/−mice only at
week 8 of infection, revealing that the concomitant deficiency
of LT and lipoxin production affects the fungal burdens
controlled by the adaptive phase of immunity. These findings
support those reported by Trista˜o et al. [34], but they are
in contrast with those of Santos et al. [36] that postulated a
prevalent role of 5-LO activity and LTs synthesis at the innate
phase of immunity [34, 36].
LTs are involved in the recruitment and activation of
inflammatory cells and play a relevant role in the control of
several inflammatory, infectious, and neoplastic diseases [14,
51–53]. In contrast, LXA
4
andATL (aspirin-triggered lipoxin)
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Figure 7: MTL treatment reduces the phagocytic ability of macrophages. For phagocytic assays, IFN-𝛾 (20 ng/mL) unprimed (a, d) and
primed (b, c, d, and f) macrophages from B10.A and A/J mice were pretreated or not with three concentrations (10−8, 10−6, and 10−4M) of
MTL.Themacrophages were then infected FITC-labeled P. brasiliensis at macrophage-yeast ratio of 1 : 1 for 2 h at 37∘C to allow fungi adhesion
and ingestion. Macrophages were washed; cells detached from plastic and were labeled with anti-CD11b APC antibodies.The cell suspensions
were immediately read on a FACSCalibur cytometer (a, b, d, and e). A quenching assay employing a trypan blue solution (TB: 250 𝜇g/mL)
was used to distinguish internalized from surface-bound yeast (c, f). Data are means ± SEM of results from quintuplicate samples from three
independent experiments. ∗∗∗𝑝 < 0.001.
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Figure 8: Exogenous lipoxin reduces, and blockade of lipoxin receptor increases the fungal loads of macrophages. IFN-𝛾 primed (20 ng/mL)
and unprimed macrophages from B10.A mice were treated with several doses of synthetic lipoxin (10−9, 10−7, and 10−6M) or a specific
antagonist of lipoxin receptor (BOcMLP) (10−5, 10−6, and 10−4M) and infected with P. brasiliensis in a macrophage-yeast cells rate of 50 : 1.
After 48 h of cocultivation, the monolayers were lysed and assayed for the presence of viable yeasts by a CFU assay. Data are means ± SEM of
results from quintuplicate samples from three independent experiments. ∗𝑝 < 0.05.
behave as potent negative regulators of inflammation due
their ability to inhibit PMN neutrophil and eosinophil traffic.
These effects are achieved by enhancing PMN clearance
from inflammatory focus without excessivemacrophage acti-
vation, modulating cytokine-stimulated metalloproteinase
activity and inhibiting cell proliferation [16]. LXA
4
produc-
tion was also involved in the prevalent synthesis of anti-
inflammatory cytokines such as IL-10 that play a fundamental
role in the resolution of inflammation [54, 55]. Here, we
have verified that MTL-treated B10.A mice displayed several
features of prevalent LX signaling. Indeed, the low influx
of PMN cells to the site of infection and the decreased
production of TNF-𝛼 and IL-12 associated with enhanced
production of IL-10 detected 48 h after infection of MLT-
treated B10.A mice indicated a prevalent LX signaling when
CysLTR
1
was blocked.The low secretion of proinflammatory
cytokines associated with the increased production of IL-10
demonstrated a shift of the initial host response toward an
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anti-inflammatory milieu. This anti-inflammatory response
concomitant with diminished fungal loads is an unusual
finding once the efficient control of P. brasiliensis growth
is mediated by proinflammatory cytokines and activated
phagocytes [5, 6, 40, 47, 56]. Furthermore, themild or regres-
sive forms of paracoccidioidomycosis have been associated
with decreased or absence of IL-10 production, respectively
[57, 58]. Despite these observations, we believe that in our
in vivo studies the less severe pulmonary infection of MTL-
treated B10.A mice could be ascribed to the improved mech-
anisms of innate immunity induced by the increased levels of
lipoxin synthesized by this mouse strain at the acute phase of
infection. Besides its potent anti-inflammatory activity, LXA4
can also exert protective effects in lung infections by increas-
ing pathogen clearance mediated by mucociliary activity of
airways. Indeed, in cystic fibrosis, a pathology associatedwith
decreased LXA
4
synthesis, administration of a stable analog
of LX leads to regulated ion transport and restored airway
surface liquid height via the ALX/FPR2 receptor, which is
expressed by epithelial cells [59, 60]. The restored airway
hydration increases the mucociliary clearance of pathogen
contributing to the improved resolution of inflammation
mediated by lipoxin. Our model is tempting to suppose that
the decreased phagocytic ability of macrophages resulted
in increased numbers of extracellular fungal cells that were
better eliminated by an improved mucociliary activity. In
addition to their anti-inflammatory activity, LXs are also
host protective by improving mucosal bacterial killing via
expression of bacterial/permeability inducing protein (BPI)
in epithelial cells [61].
Our additional studieswith in vitro infectedmacrophages
recapitulated our in vivo findings and demonstrated that
the decreased ingestion of P. brasiliensis yeast by inflam-
matory phagocytes could account, at least partially, for the
reduced fungal loads. Importantly, the phagocytic assays
using PI-labeled P. brasiliensis yeasts explained the low CFU
counts observed in the fungicidal analyses and suggested
that the CysLTR
1
blockade resulted in impaired interaction
betweenmacrophages and fungal cells. Moreover, the in vitro
treatments of macrophages with exogenous lipoxin and an
antagonist of lipoxin receptor demonstrated that CysLTs exert
an activating effect, whereas lipoxin inhibits the interaction
betweenmacrophages and P. brasiliensis yeasts.This impaired
interaction could be explained by the decreased expression of
pathogen recognition receptors (PRRs) by lipoxin-stimulated
macrophages [48, 62, 63]. Our previous studies have demon-
strated that the absence of TLRs expression or MyD88 sig-
naling results in decreased interaction ofmacrophages with P.
brasiliensis cells [9, 37, 38, 56].Wehave also reported that CR3
(CD11b/CD18) plays a fundamental role in the interaction
of B10.A macrophages with P. brasiliensis yeasts, in contrast
with A/J macrophages that preferentially use Dectin-1 and
MR to sense P. brasiliensis infection [7]. Here, a decreased
expression of CD11b and TLR2 was observed following MTL
treatment possibly contributing to the inhibited recognition
of P. brasiliensis by B10.A macrophages. Interestingly, lipoxin
was also shown to exert an anti-inflammatory effect in
periodontal disease caused by Porphyromonas gingivalis by
impairing the expression of CR3 [48].
Previous studies with resistant and susceptible mice to
P. brasiliensis infection have demonstrated that an elevated
activation of innate immunity does not necessarily lead to
less severe infections or better disease outcomes [6–9, 37,
38]. Early after P. brasiliensis infection, susceptible B10.A
mice mount a more vigorous, PMN-rich, proinflammatory
reaction than resistant A/J mice [47]. An increased killing
ability associated with elevated IL-12 and NO secretion is a
feature of alveolar macrophages and DCs from susceptible
mice, whereas a preferential secretion of TGF-𝛽 impaired
inflammatory and fungicidal activities, the behavior of A/J
cells. Thus, the production of proinflammatory mediators
such as IL-12, TNF-𝛼, IFN-𝛾, and LTs is essential to control
microbial growth during infection, but their effects have to be
regulated by anti-inflammatory mechanisms and mediators
to avoid excessive tissue destruction and suppression of
adaptive immunity as what occurs with susceptible mice
[11, 58]. Murine cerebral malaria, toxoplasmosis, and tuber-
culosis are other examples of infections where excessive
proinflammatory response results in severe tissue pathology
that, however, is counter-regulated by lipoxin production
[24, 25, 64]. In sum, a balanced and efficient immunity to a
microbial infection must express a proinflammatory activity
to control pathogen growth, but this activity must be tightly
regulated by anti-inflammatorymechanisms to guarantee the
integrity of host tissues.
In pulmonary paracoccidioidomycosis, the protective
effect of CysLTR
1
blockade that results in less severe infection
was not previously described. Furthermore, prevalent lipoxin
secretion and signaling that have been previously described as
an escape mechanism of pathogens [24] was here associated
with host immunoprotection. In pulmonary paracoccid-
ioidomycosis of susceptible B10.A mice, whose susceptibility
is based in the early excessive proinflammatory responses, the
inhibitory effect of lipoxin signaling could exert a beneficial
effect. Importantly, even in human paracoccidioidomycosis
the excessive activation of the immune system can be deleteri-
ous, and in some cases an effective therapy is only achieved if
the antifungal treatment is associatedwith anti-inflammatory
drugs [65, 66].
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